Difference between revisions of "Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5 (Q9864)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): By Kunthel, #quickstatements; #temporary_batch_1589998140706) |
(Created claim: Third Author string (P151): Subramaniam Sriram, #quickstatements; #temporary_batch_1589999365427) |
||
| Property / Third Author string | |||
| + | Subramaniam Sriram | ||
| Property / Third Author string: Subramaniam Sriram / rank | |||
| + | Normal rank | ||
Revision as of 18:33, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Norsworthy Kelly J.
0 references
By Kunthel
0 references
Subramaniam Sriram
0 references
